안티센스 및 RNAi 치료제 시장 점유율 분석 및 기회 [2025-2031]
Antisense and RNAi Therapeutics Market Report Analysis
Antisense and RNAi Therapeutics Market
-
CAGR (2025 - 2031)7.50% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals
- Benitec Biopharma Ltd.
- Quark Pharmaceuticals
- Ionis Pharmaceuticals
- Astellas Pharma Inc
- Marina Biosciences
- Sanofi S
- Dicerna Pharmaceuticals
- Tekmira Pharmaceuticals
Regional Overview

- 북미
- 유럽
- 아시아 태평양
- 남미 및 중앙아메리카
- 중동 및 아프리카
Market Segmentation

- RNA 간섭
- 안티센스 RNA

- 폐 투여
- 정맥 주사
- 피내 투여
- 복강 내 투여
- 국소 투여
- 기타

- 감염성 질환
- 심혈관 질환
- 암
- 신경계 질환
- 기타

- 북미
- 유럽
- 아시아 태평양
- 남미 및 중미
- 중동 및 아프리카